chrX-120626227-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001011551.3(C1GALT1C1):āc.940G>Cā(p.Gly314Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000058 in 1,207,154 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001011551.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1GALT1C1 | NM_001011551.3 | c.940G>C | p.Gly314Arg | missense_variant | 2/2 | ENST00000304661.6 | |
C1GALT1C1 | NM_152692.5 | c.940G>C | p.Gly314Arg | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1GALT1C1 | ENST00000304661.6 | c.940G>C | p.Gly314Arg | missense_variant | 2/2 | 1 | NM_001011551.3 | P1 | |
C1GALT1C1 | ENST00000371313.2 | c.940G>C | p.Gly314Arg | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 3AN: 113074Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35218
GnomAD3 exomes AF: 0.0000223 AC: 4AN: 179618Hom.: 0 AF XY: 0.0000466 AC XY: 3AN XY: 64374
GnomAD4 exome AF: 0.00000366 AC: 4AN: 1094080Hom.: 0 Cov.: 30 AF XY: 0.00000278 AC XY: 1AN XY: 359880
GnomAD4 genome AF: 0.0000265 AC: 3AN: 113074Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35218
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.940G>C (p.G314R) alteration is located in exon 3 (coding exon 1) of the C1GALT1C1 gene. This alteration results from a G to C substitution at nucleotide position 940, causing the glycine (G) at amino acid position 314 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Polyagglutinable erythrocyte syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 849367). This variant has not been reported in the literature in individuals affected with C1GALT1C1-related conditions. This variant is present in population databases (rs749131756, gnomAD 0.03%). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 314 of the C1GALT1C1 protein (p.Gly314Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at